Blackstone’s Caris Life Sciences CAI Stock Holding History
Bought
Maintained
Sold
Other funds holding CAI
Blackstone's CAI Position: Q3 2026 in Review
Blackstone opened a new position in Caris Life Sciences (CAI) in Q3 2026: 418,109 shares worth $12.8M. The stake represents 0.04% of the portfolio and ranks #83 among its holdings. This is a return to the name: Blackstone previously reported a position in CAI as recently as Q2 2025.
Blackstone first reported a position in CAI in Q2 2025 and has held it in 2 quarters since. 330 funds tracked by Wall St. Rank hold CAI as of Q3 2026.
- Blackstone held 418,109 shares of Caris Life Sciences worth $12.8M as of Q3 2026.
- Caris Life Sciences was a new Blackstone position in Q3 2026.
- Caris Life Sciences made up 0.04% of Blackstone's portfolio in Q3 2026, its #83 holding.
- Blackstone first reported a position in Caris Life Sciences in Q2 2025 and has held it in 2 quarters since.
- 330 funds tracked by Wall St. Rank held Caris Life Sciences as of Q3 2026.
Based on Blackstone's 13F filing for Q3 2026, filed 16 Nov 2026.